Chugai Pharmaceutical Co. Ltd.'s Fiscal Year is From January To December - All Figures are in JPY, Billions.
The item "Tax-Provision" stands at 160.73 Billion Japanese Yens for the trailing twelve months (TTM) period ending 06/30/2025.
Chugai Pharmaceutical Co. Ltd.'s second quarter result of 38.85 Billion JPY for the item "Tax Provision" represents an increase of 0.65 percent compared to it's first quarter result.
Also, Chugai Pharmaceutical Co. Ltd.'s second quarter result of 38.85 Billion JPY for the item "Tax Provision" represents a decrease of -17.25 percent compared to it's second quarter result of last year.
Looking again at the trailing twelve months series (TTM), Chugai Pharmaceutical Co. Ltd.'s second quarter result of 160.73 Billion JPY for the item "Tax Provision" represents a decrease of -4.79 percent compared to it's first quarter result.
Regarding the One-Year-Change of the series, the current value constitutes an increase of 20.11 percent compared to the value the year prior.
The 1 year change in percent is 20.11.
The 3 year change in percent is 3.01.
The 5 year change in percent is 154.80.
The 10 year change in percent is 594.81.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Tax Provision | 905,699,262,464.00 |
![]() | Johnson & Johnson - Tax Provision | 486,508,953,600.00 |
![]() | AbbVie Inc - Tax Provision | 399,570,305,024.00 |
![]() | Roche Holding AG - Tax Provision | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Tax Provision | 280,205,508,085.11 |